Free tool
FAERS Monitor: Photofrin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020451 or its brand name (Photofrin, Porfimer Sodium). Reports on generic versions are filed under their own applications.
Reports
341
Serious
313
92% of reports
Hospitalization
103
Death reported
74
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use72
- cholangitis42
- oesophageal stenosis28
- dyspnoea19
- hypotension19
- sepsis15
- photosensitivity reaction14
- pneumonia14
- post procedural complication14
- swelling face13
- deep vein thrombosis12
- fatigue11
- nausea11
- pyrexia11
- atrial fibrillation10
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5 |
| 2005 | 17 |
| 2006 | 33 |
| 2007 | 31 |
| 2008 | 7 |
| 2009 | 16 |
| 2010 | 18 |
| 2011 | 5 |
| 2012 | 52 |
| 2013 | 22 |
| 2014 | 12 |
| 2015 | 30 |
| 2016 | 23 |
| 2017 | 15 |
| 2018 | 7 |
| 2019 | 10 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,818 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| oesophageal stenosisSignal | 28 | 613.3 | 429.2 | 16,348 |
| cholangitisSignal | 42 | 420.7 | 316.6 | 17,057 |
| photosensitivity reactionSignal | 14 | 52.3 | 31.3 | 655 |
| post procedural complicationSignal | 14 | 45.0 | 26.9 | 559 |
| swelling faceSignal | 13 | 12.3 | 7.2 | 124 |
| deep vein thrombosisSignal | 12 | 11.4 | 6.5 | 104 |
| sepsisSignal | 15 | 8.3 | 5.1 | 90 |
| atrial fibrillationSignal | 10 | 6.3 | 3.4 | 40 |
| hypotensionSignal | 19 | 5.8 | 3.8 | 72 |
| off label useSignal | 72 | 5.1 | 4.1 | 241 |
| pneumoniaSignal | 14 | 2.7 | 1.6 | 13 |
| dyspnoeaSignal | 19 | 2.1 | 1.3 | 10 |
| pyrexia | 11 | 2.0 | 1.1 | 4 |
| fatigue | 11 | 0.9 | 0.5 | 0 |
| nausea | 11 | 0.9 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.